Inventor
Weimei SUN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds23%
C07HSugars18%
C07BGeneral methods of organic chemistry14%
PatentTitleYear
12,145,961Spirobicyclic analogues202411,993,614Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors202411,883,3676-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors202411,702,441Spirobicyclic analogues202311,318,1576-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to JANSSEN PHARMACEUTICA NV (5)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 5 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2024 |